FLCCC shares that, like penicillin and aspirin, ivermectin is a medication that derives from nature.

It has been used since the 1970s and has a long safety and efficacy track record. Ivermectin works by inhibiting the replication of COVID-19, flu, and many other viruses. It has also demonstrated effectiveness in preventing transmission of COVID-19 when taken before or even after exposure. It also acts to subdue the inflammation caused by COVID-19, lowers viral loads, protects against organ damage, and lowers the risk of hospitalization and death (Infected by Ralph LaGuardia, M.D.)

Although it was little known in advanced health economies before COVID, the drug has an incredible history of promoting health in underdeveloped countries. Approved for human use in 1987, it has been instrumental in tackling some of the world’s most harmful tropical diseases, such as Onchocerciasis, lymphatic filariasis (also known as Elephantiasis), strongyloidiasis, and scabies. It also effectively fights parasitic infestations in animals, which can be economically devastating to the livestock industry.

In addition to being an effective, broad-spectrum anti-parasitic, many healthcare professionals have been using ivermectin for decades to treat various other diseases.

“Few, if any, other drugs can rival ivermectin for its beneficial impact on human health and welfare,” wrote Andy Crump in The Journal of Antibiotics in 2017. For decades, Crump worked with Satoshi Ōmura, the Japanese microbiologist responsible for discovering ivermectin.

Ivermectin is one of the safest drugs known. It is on the World Health Organization’s list of essential medicines, has been given over 4 billion times around the globe, and has won the Nobel Prize for its global and historic impacts in eradicating endemic parasitic infections in many parts of the world.

It is important to look at evidence from all sources when deciding whether to use a particular treatment approach. FLCCC used the totality of evidence approach when deciding whether to recommend ivermectin as a potential treatment for COVID-19.